Variation in use of dual-chamber implantable cardioverter-defibrillators: Results from the National Cardiovascular Data Registry

Archives of Internal Medicine

Volumn 172, Issue 8, 2012, Pages 634-641

  Matlock, Dan D ^a,b,c   Peterson, Pamela N ^a,b,c,d   Wang, Yongfei ^e   Curtis, Jeptha P ^e   Reynolds, Matthew R ^f   Varosy, Paul D ^a,b,g   Masoudi, Frederick A ^a,b,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Colorado Cardiovascular Outcomes Research Group ^*  (United States)

^c KAISER PERMANENTE   (United States)

^d DENVER HEALTH MEDICAL CENTER   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g Veterans Affairs Eastern Colorado Health Care System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CROSS-SECTIONAL STUDY; DEFIBRILLATOR; DUAL CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PACEMAKER; PACIFIC ISLANDS; PRIMARY PREVENTION; PRIORITY JOURNAL; UNITED STATES;

AGED; CLUSTER ANALYSIS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT DESIGN; FEMALE; HOSPITALS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW ENGLAND; ODDS RATIO; PACEMAKER, ARTIFICIAL; PACIFIC STATES; PREDICTIVE VALUE OF TESTS; PRIMARY PREVENTION; REGISTRIES;

EID: 84860383256     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2012.394     Document Type: Article

References (45)

1. Bardy GH, Lee KL, Mark DB, et al Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225-237. (Pubitemid 40110811)
2. Kadish A, Dyer A, Daubert JP, et al Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350(21):2151-2158. (Pubitemid 38637995)
3. Moss AJ, Zareba W, Hall WJ, et al; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877-883. (Pubitemid 34984635)
4. McClellan MB, Tunis SR. Medicare coverage of ICDs. N Engl J Med. 2005;352(3):222-224. (Pubitemid 40110810)
5. Centers for Medicare and Medicaid Services. National coverage decision for implantable automatic defibrillators. http://www.cms.gov/medicare-coverage- database/details/ncd-details.aspx?NCDId=110&ncdver=3&CoverageSelection= National&KeyWord=defibrillators&KeyWordLookUp=Title& KeyWordSearchType=And&ncd-id=20.4&ncd-version=3&basket= ncd%25253A20%25252E4%25253A3%25253AImplantable+Automatic+Defibrillators&bc= gAAAABAAAAAA&. Accessed January 9, 2012.
6. Epstein AE, DiMarco JP, Ellenbogen KA, et al American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117(21):e350-e408.
7. Dewland TA, Pellegrini CN, Wang Y, Marcus GM, Keung E, Varosy PD. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. J Am Coll Cardiol. 2011;58(10):1007-1013.
8. Kadish A, Mehra M. Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy. Circulation. 2005;111(24):3327-3335. (Pubitemid 40875007)
9. Almendral J, Arribas F, Wolpert C, et al DATAS Steering Committee; DATAS Writing Committee; DATAS Investigators. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial. Europace. 2008;10(5):528-535. (Pubitemid 351775295)
10. Theuns DAMJ, Klootwijk AP, Goedhart DM, Jordaens LJLM. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol. 2004;44(12):2362-2367. (Pubitemid 39647611)
11. Deisenhofer I, Kolb C, Ndrepepa G, et al. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? a randomized, prospective study. J Cardiovasc Electrophysiol. 2001;12(2):134-142. (Pubitemid 32171500)
12. Friedman PA, McClelland RL, Bamlet WR, et al. Dual-chamber vs single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation. 2006;113(25):2871-2879. (Pubitemid 44297227)
13. Wilkoff BL, Cook JR, Epstein AE, et al Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002;288(24):3115-3123. (Pubitemid 36014128)
14. Wilkoff BL, Kudenchuk PJ, Buxton AE, et al; DAVID II Investigators. The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial. J Am Coll Cardiol. 2009;53(10):872-880.
15. Olshansky B, Day JD, Moore S, et al. Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study. Circulation. 2007;115(1):9-16. (Pubitemid 46058606)
16. The American College of Cardiology. National Cardiovascular Data Registry. http://www.ncdr.com/webncdr/ICD/Default.aspx. Accessed January 9, 2012.
17. Hammill SC, Kremers MS, Kadish AH, et al. Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm. 2009;6(9):1397-1401.
18. US Census, 2010. http://2010.census.gov/2010census/. Accessed February 15, 2012.
19. The Dartmouth Atlas of Health Care. http://www.dartmouthatlas.org. Accessed January 9, 2012.
20. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending: part 1: the content, quality, and accessibility of care. Ann Intern Med. 2003;138(4):273-287. (Pubitemid 36205924)
21. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending: part 2: health outcomes and satisfaction with care. Ann Intern Med. 2003;138(4):288-298. (Pubitemid 36205925)
22. Sirovich B, Gallagher PM, Wennberg DE, Fisher ES. Discretionary decision making by primary care physicians and the cost of U.S. Health care. Health Aff (Millwood). 2008;27(3):813-823. (Pubitemid 351770251)
23. Curtis JP, Luebbert JJ, Wang Y, et al. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA. 2009;301(16):1661-1670.
24. Al-Khatib SM, Hellkamp A, Curtis J, et al. Non-evidence-based ICD implantations in the United States. JAMA. 2011;305(1):43-49.
25. Larsen K, Petersen JH, Budtz-Jørgensen E, Endahl L. Interpreting parameters in the logistic regression model with random effects. Biometrics. 2000;56(3):909-914.
26. Chan PS, Nichol G, Krumholz HM, Spertus JA, Nallamothu BK; American Heart Association National Registry of Cardiopulmonary Resuscitation (NRCPR) Investigators. Hospital variation in time to defibrillation after in-hospital cardiac arrest. Arch Intern Med. 2009;169(14):1265-1273.
27. Ricci RP, Quesada A, Almendral J, et al; DATAS study Investigators. Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial. Europace. 2009;11(5):587-593.
28. Bach PB. A map to bad policy: hospital efficiency measures in the Dartmouth Atlas. N Engl J Med. 2010;362(7):569-574.
29. Ong MK, Mangione CM, Romano PS, et al. Looking forward, looking back: assessing variations in hospital resource use and outcomes for elderly patients with heart failure. Circ Cardiovasc Qual Outcomes. 2009;2(6):548-557.
30. Anderson HV. Regional variation: only moderately interesting: a word of caution. Circ Cardiovasc Qual Outcomes. 2010;3(1):6-7.
31. Sutherland JM, Fisher ES, Skinner JS. Getting past denial: the high cost of health care in the United States. N Engl J Med. 2009;361(13):1227-1230.
32. Matlock DD, Kutner JS, Emsermann CB, et al. Regional variations in physicians'attitudes and recommendations surrounding implantable cardioverter-defibrillators. J Card Fail. 2011;17(4):318-324.
33. Godin G, Bélanger-Gravel A, Eccles M, Grimshaw J. Healthcare professionals'intentions and behaviours: a systematic review of studies based on social cognitive theories. Implement Sci. 2008;3(1):36.
34. Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q. 2004;82(4):581-629. (Pubitemid 40143100)
35. Rogers E. Diffusion of Innovations. New York, NY: Free Press; 1962.
36. Barnato AE, Bost JE, Farrell MH, et al. Relationship between staff perceptions of hospital norms and hospital-level end-of-life treatment intensity. J Palliat Med. 2007;10(5):1093-1100. (Pubitemid 350073549)
37. Lin CY, Farrell MH, Lave JR, Angus DC, Barnato AE. Organizational determinants of hospital end-of-life treatment intensity. Med Care. 2009;47(5):524-530.
38. Goldberger Z, Elbel B, McPherson CA, Paltiel AD, Lampert R. Cost advantage of dual-chamber versus single-chamber cardioverter-defibrillator implantation. J Am Coll Cardiol. 2005;46(5):850-857. (Pubitemid 41224810)
39. Dobrzynski H, Boyett MR, Anderson RH. New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation. 2007;115(14):1921-1932. (Pubitemid 46598906)
40. Groeneveld PW, Laufer SB, Garber AM. Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989-2000. Med Care. 2005;43(4):320-329. (Pubitemid 40515621)
41. Lucas FL, Sirovich BE, Gallagher PM, Siewers AE, Wennberg DE. Variation in cardiologists' propensity to test and treat: is it associated with regional variation in utilization? Circ Cardiovasc Qual Outcomes. 2010;3(3):253-260.
42. Critics question study cited in health debate. Abelson R, Harris G. New York Times. June 2, 2011. http://www.nytimes.com/2010/06/03/business/ 03dartmouth.html?pagewanted=all. Accessed February 15, 2012.
43. Maynard A. The powers and pitfalls of payment for performance. Health Econ. 2012;21(1):3-12.
44. Anthony DL, Herndon MB, Gallagher PM, et al. How much do patients' preferences contribute to resource use? Health Aff (Millwood). 2009;28(3):864-873.
45. Fowler FJ Jr, Gallagher PM, Anthony DL, Larsen K, Skinner JS. Relationship between regional per capita Medicare expenditures and patient perceptions of quality of care. JAMA. 2008;299(20):2406-2412. (Pubitemid 351749239)